| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency | 2 | 2012 | 121 | 0.650 |
Why?
|
| Kidney | 4 | 2021 | 945 | 0.600 |
Why?
|
| Kidney Diseases | 3 | 2019 | 307 | 0.570 |
Why?
|
| Kidney Glomerulus | 4 | 2021 | 155 | 0.550 |
Why?
|
| Podocytes | 4 | 2021 | 113 | 0.500 |
Why?
|
| Proteinuria | 3 | 2012 | 136 | 0.490 |
Why?
|
| Glomerulonephritis | 2 | 2019 | 77 | 0.480 |
Why?
|
| Kidney Transplantation | 6 | 2019 | 839 | 0.480 |
Why?
|
| Thrombopoietin | 1 | 2013 | 15 | 0.450 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2013 | 8 | 0.450 |
Why?
|
| Hyperlipoproteinemia Type I | 1 | 2013 | 3 | 0.440 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 36 | 0.430 |
Why?
|
| Acute Kidney Injury | 2 | 2013 | 232 | 0.430 |
Why?
|
| Ganglionic Stimulants | 1 | 2012 | 15 | 0.410 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 376 | 0.400 |
Why?
|
| Kidney Failure, Chronic | 3 | 2019 | 365 | 0.380 |
Why?
|
| Nephrectomy | 1 | 2011 | 103 | 0.370 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 4 | 2019 | 43 | 0.370 |
Why?
|
| Albuminuria | 1 | 2011 | 171 | 0.370 |
Why?
|
| Tissue Donors | 1 | 2011 | 195 | 0.340 |
Why?
|
| Tropomyosin | 1 | 2008 | 4 | 0.330 |
Why?
|
| Lamin Type A | 1 | 2008 | 9 | 0.330 |
Why?
|
| Vimentin | 1 | 2008 | 47 | 0.330 |
Why?
|
| Nicotine | 1 | 2012 | 350 | 0.330 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2007 | 14 | 0.300 |
Why?
|
| Glomerular Mesangium | 3 | 2003 | 53 | 0.300 |
Why?
|
| Gadolinium | 1 | 2007 | 88 | 0.290 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2013 | 756 | 0.280 |
Why?
|
| Skin Diseases | 1 | 2007 | 122 | 0.270 |
Why?
|
| RNA, Messenger | 5 | 2019 | 1663 | 0.270 |
Why?
|
| Angiotensin II | 3 | 1992 | 220 | 0.250 |
Why?
|
| Blood Pressure | 1 | 2011 | 1449 | 0.250 |
Why?
|
| Brain Diseases | 1 | 2005 | 78 | 0.250 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2003 | 15 | 0.230 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2003 | 19 | 0.230 |
Why?
|
| Hyponatremia | 1 | 2003 | 20 | 0.230 |
Why?
|
| Hypertension | 2 | 2011 | 1533 | 0.210 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 63 | 0.190 |
Why?
|
| Male | 24 | 2019 | 37283 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 2 | 2019 | 384 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 2222 | 0.180 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 1990 | 16 | 0.170 |
Why?
|
| Animals | 15 | 2021 | 20880 | 0.170 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1990 | 43 | 0.170 |
Why?
|
| Oxidative Stress | 1 | 2003 | 718 | 0.170 |
Why?
|
| Rats | 8 | 2017 | 5300 | 0.170 |
Why?
|
| Formoterol Fumarate | 1 | 2019 | 25 | 0.170 |
Why?
|
| Glutamyl Aminopeptidase | 2 | 2017 | 12 | 0.170 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2019 | 18 | 0.170 |
Why?
|
| Myosin Type I | 1 | 2019 | 20 | 0.160 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 27 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 3 | 1992 | 511 | 0.160 |
Why?
|
| Biological Assay | 1 | 2019 | 88 | 0.160 |
Why?
|
| Natriuretic Agents | 1 | 1998 | 9 | 0.160 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 138 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2021 | 617 | 0.140 |
Why?
|
| Humans | 34 | 2021 | 68549 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 248 | 0.140 |
Why?
|
| Isoantibodies | 2 | 2008 | 35 | 0.140 |
Why?
|
| Calciphylaxis | 1 | 1996 | 7 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 274 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2021 | 2689 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2012 | 514 | 0.130 |
Why?
|
| Rats, Wistar | 2 | 2008 | 371 | 0.130 |
Why?
|
| Adult | 12 | 2013 | 21379 | 0.130 |
Why?
|
| Brain | 1 | 2005 | 2176 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2014 | 29 | 0.120 |
Why?
|
| Blood Component Removal | 1 | 2014 | 19 | 0.120 |
Why?
|
| Heterocyclic Compounds | 1 | 2014 | 24 | 0.120 |
Why?
|
| Antigens, CD34 | 1 | 2014 | 75 | 0.120 |
Why?
|
| Mitochondria | 1 | 2019 | 643 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2003 | 1242 | 0.120 |
Why?
|
| Female | 17 | 2019 | 38021 | 0.110 |
Why?
|
| Receptors, Fc | 1 | 2013 | 19 | 0.110 |
Why?
|
| Plasma Exchange | 1 | 2013 | 18 | 0.110 |
Why?
|
| Blood Viscosity | 1 | 2013 | 9 | 0.110 |
Why?
|
| Plasmapheresis | 1 | 2013 | 18 | 0.110 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 135 | 0.110 |
Why?
|
| Mycophenolic Acid | 1 | 2012 | 62 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 268 | 0.110 |
Why?
|
| Triglycerides | 1 | 2013 | 184 | 0.100 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2010 | 50 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 122 | 0.100 |
Why?
|
| Cyclosporine | 1 | 2012 | 121 | 0.100 |
Why?
|
| Fibrosis | 2 | 2019 | 371 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2012 | 150 | 0.100 |
Why?
|
| Cell Line | 3 | 2021 | 1752 | 0.100 |
Why?
|
| Oligopeptides | 1 | 1992 | 152 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 2550 | 0.100 |
Why?
|
| Antibody Diversity | 1 | 1990 | 7 | 0.090 |
Why?
|
| Renal Dialysis | 2 | 2005 | 174 | 0.090 |
Why?
|
| Azotemia | 1 | 2010 | 2 | 0.090 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 4 | 0.090 |
Why?
|
| Mice | 6 | 2021 | 8474 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 546 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2021 | 1200 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 562 | 0.090 |
Why?
|
| Angiotensin I | 1 | 2009 | 24 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2011 | 737 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 32 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2008 | 246 | 0.080 |
Why?
|
| Doxorubicin | 2 | 2019 | 231 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 284 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 1851 | 0.070 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2007 | 8 | 0.070 |
Why?
|
| Pregnancy | 1 | 2013 | 2334 | 0.070 |
Why?
|
| Biomarkers | 2 | 2010 | 1593 | 0.070 |
Why?
|
| Adolescent | 6 | 2012 | 8904 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 614 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2003 | 2673 | 0.070 |
Why?
|
| Middle Aged | 7 | 2014 | 21119 | 0.070 |
Why?
|
| Prevalence | 1 | 2011 | 1609 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 483 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1860 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 2 | 1998 | 54 | 0.070 |
Why?
|
| Calcineurin Inhibitors | 1 | 2005 | 24 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 40 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 161 | 0.060 |
Why?
|
| Lupus Nephritis | 1 | 2007 | 193 | 0.060 |
Why?
|
| Young Adult | 2 | 2013 | 5710 | 0.060 |
Why?
|
| Sarcoidosis | 4 | 1973 | 77 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2011 | 2004 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2265 | 0.060 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1140 | 0.060 |
Why?
|
| Hemangiopericytoma | 1 | 1984 | 5 | 0.060 |
Why?
|
| Thoracic Neoplasms | 1 | 1984 | 10 | 0.060 |
Why?
|
| South Carolina | 1 | 2011 | 2752 | 0.060 |
Why?
|
| Thioctic Acid | 1 | 2003 | 6 | 0.060 |
Why?
|
| Contrast Media | 1 | 2007 | 595 | 0.060 |
Why?
|
| Growth Substances | 1 | 2003 | 77 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2019 | 1692 | 0.060 |
Why?
|
| Vasopressins | 1 | 2003 | 33 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2003 | 136 | 0.060 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1983 | 12 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2003 | 126 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 4655 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 250 | 0.050 |
Why?
|
| Nephritis, Hereditary | 1 | 2002 | 8 | 0.050 |
Why?
|
| Graft Survival | 2 | 2002 | 465 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2021 | 32 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2014 | 7268 | 0.050 |
Why?
|
| Antioxidants | 1 | 2003 | 304 | 0.050 |
Why?
|
| Bronchial Neoplasms | 2 | 1976 | 12 | 0.050 |
Why?
|
| Pancreas Transplantation | 1 | 2001 | 71 | 0.050 |
Why?
|
| Risk Factors | 1 | 2011 | 5720 | 0.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2001 | 69 | 0.050 |
Why?
|
| Lung Diseases | 3 | 1973 | 175 | 0.050 |
Why?
|
| Calcium | 2 | 1996 | 929 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2001 | 114 | 0.040 |
Why?
|
| Thrombosis | 1 | 2001 | 218 | 0.040 |
Why?
|
| Factor V | 1 | 2000 | 20 | 0.040 |
Why?
|
| Renal Artery Obstruction | 1 | 2000 | 29 | 0.040 |
Why?
|
| Partial Thromboplastin Time | 1 | 2000 | 57 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 1990 | 98 | 0.040 |
Why?
|
| Aged | 5 | 2014 | 14842 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2019 | 51 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2019 | 34 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2019 | 34 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 2083 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 58 | 0.040 |
Why?
|
| Recurrence | 2 | 2019 | 948 | 0.040 |
Why?
|
| Luciferases | 1 | 2019 | 105 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 46 | 0.040 |
Why?
|
| Rabbits | 2 | 1990 | 509 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 191 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 88 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2000 | 125 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 196 | 0.040 |
Why?
|
| Protein Binding | 1 | 2021 | 1027 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 455 | 0.040 |
Why?
|
| Dactinomycin | 1 | 1998 | 31 | 0.040 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 12 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2010 | 1465 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1998 | 50 | 0.040 |
Why?
|
| Drug Stability | 1 | 1998 | 71 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1998 | 32 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 45 | 0.040 |
Why?
|
| ROC Curve | 1 | 2019 | 392 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 214 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 498 | 0.030 |
Why?
|
| Phosphorus | 1 | 1996 | 64 | 0.030 |
Why?
|
| Skin Ulcer | 1 | 1996 | 19 | 0.030 |
Why?
|
| Mediastinum | 1 | 1976 | 39 | 0.030 |
Why?
|
| Parathyroidectomy | 1 | 1996 | 45 | 0.030 |
Why?
|
| Lymphoma | 2 | 2014 | 116 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1996 | 164 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1996 | 102 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 4 | 1969 | 61 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 1976 | 156 | 0.030 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2014 | 10 | 0.030 |
Why?
|
| Autografts | 1 | 2014 | 22 | 0.030 |
Why?
|
| Benzylamines | 1 | 2014 | 28 | 0.030 |
Why?
|
| Lung Abscess | 2 | 1965 | 4 | 0.030 |
Why?
|
| Base Sequence | 2 | 1993 | 1015 | 0.030 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 1993 | 11 | 0.030 |
Why?
|
| Autoantibodies | 1 | 1996 | 434 | 0.030 |
Why?
|
| Sepsis | 1 | 1976 | 233 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 2014 | 92 | 0.030 |
Why?
|
| Tomography, X-Ray | 1 | 1973 | 1 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1293 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1993 | 1446 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 2077 | 0.030 |
Why?
|
| Algorithms | 2 | 2010 | 1195 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 114 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1641 | 0.030 |
Why?
|
| Receptors, Angiotensin | 1 | 1992 | 59 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 532 | 0.030 |
Why?
|
| Dinoprostone | 1 | 1992 | 110 | 0.020 |
Why?
|
| Prognosis | 1 | 1996 | 2093 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1992 | 155 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 648 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1990 | 57 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2010 | 12 | 0.020 |
Why?
|
| Urinalysis | 1 | 2010 | 27 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 1082 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2010 | 104 | 0.020 |
Why?
|
| Neprilysin | 1 | 2009 | 55 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1990 | 954 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1992 | 1745 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 246 | 0.020 |
Why?
|
| Epitopes | 1 | 1988 | 146 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1988 | 420 | 0.020 |
Why?
|
| Lung | 2 | 1962 | 849 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 306 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 219 | 0.020 |
Why?
|
| Creatinine | 1 | 2007 | 243 | 0.020 |
Why?
|
| Echinococcosis, Pulmonary | 1 | 1965 | 2 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 3187 | 0.020 |
Why?
|
| Pleural Diseases | 1 | 1965 | 20 | 0.020 |
Why?
|
| Radiography | 2 | 1983 | 572 | 0.020 |
Why?
|
| Tuberculosis | 3 | 1961 | 77 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2012 | 3703 | 0.020 |
Why?
|
| Yugoslavia | 2 | 1983 | 10 | 0.020 |
Why?
|
| Germany, East | 1 | 1983 | 2 | 0.010 |
Why?
|
| Methods | 2 | 1973 | 156 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1983 | 123 | 0.010 |
Why?
|
| Mediastinal Cyst | 1 | 1962 | 5 | 0.010 |
Why?
|
| Echinococcus | 1 | 1962 | 1 | 0.010 |
Why?
|
| Echinococcosis | 1 | 1962 | 5 | 0.010 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2002 | 15 | 0.010 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 1962 | 7 | 0.010 |
Why?
|
| Trachea | 1 | 1962 | 48 | 0.010 |
Why?
|
| Bronchi | 1 | 1961 | 59 | 0.010 |
Why?
|
| Child | 1 | 2012 | 6401 | 0.010 |
Why?
|
| Cysts | 1 | 1962 | 70 | 0.010 |
Why?
|
| Medical Records | 1 | 1961 | 121 | 0.010 |
Why?
|
| Adenoma | 1 | 1961 | 132 | 0.010 |
Why?
|
| Renal Veins | 1 | 2000 | 18 | 0.010 |
Why?
|
| Renal Artery | 1 | 2000 | 29 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2000 | 216 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 658 | 0.010 |
Why?
|
| Mediastinal Diseases | 1 | 1976 | 15 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 1 | 1976 | 27 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 1213 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 1953 | 5 | 0.010 |
Why?
|
| Niacin | 1 | 1953 | 12 | 0.010 |
Why?
|
| Isoniazid | 1 | 1953 | 20 | 0.010 |
Why?
|
| Thymidine | 1 | 1993 | 32 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1993 | 35 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 35 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1993 | 109 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1993 | 165 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 189 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1976 | 705 | 0.010 |
Why?
|
| Mediastinoscopy | 1 | 1973 | 13 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1961 | 1172 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1973 | 219 | 0.010 |
Why?
|
| DNA Replication | 1 | 1993 | 167 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 492 | 0.010 |
Why?
|
| Pneumonolysis | 1 | 1951 | 1 | 0.010 |
Why?
|
| Thoracoplasty | 1 | 1951 | 2 | 0.010 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 1951 | 3 | 0.010 |
Why?
|
| Kinetics | 1 | 1993 | 1047 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1973 | 186 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 1951 | 91 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1993 | 682 | 0.010 |
Why?
|
| Neoplasms | 1 | 1961 | 1664 | 0.010 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 1969 | 2 | 0.010 |
Why?
|
| Ethambutol | 1 | 1969 | 6 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1969 | 30 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1969 | 274 | 0.010 |
Why?
|
| Pneumonectomy | 1 | 1965 | 79 | 0.000 |
Why?
|
| Cerebral Decortication | 1 | 1962 | 1 | 0.000 |
Why?
|
| Pneumothorax, Artificial | 1 | 1962 | 2 | 0.000 |
Why?
|
| Pleura | 1 | 1962 | 25 | 0.000 |
Why?
|
| Pneumothorax | 1 | 1962 | 42 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1969 | 258 | 0.000 |
Why?
|
| Biopsy | 1 | 1969 | 539 | 0.000 |
Why?
|